Cumberland Pharmaceuticals Strikes Amid Official FDA Approval

Cumberland Caldolor has been approved by the FDA to be used in pre-operative settings to relieve severe pain. This new labeling feature allows patients to administer the drug just before they go into surgery. The new label for this product provides statistics about its uses and safety, as well as the possible side effects and other details about its use. CPIX stock strikes as the results go overloading the head in the pre-market, jumping 98% to cost $4.36 from $2.20.

A study on patients with orthopedic surgical pain showed that Caldolor reduced the pain significantly after being given for six hours before and after the operation. The study also demonstrated that the drug provided a statistically notable improvement in pain intensity over 24 hours following the procedure. According to Dr. Stephen Southworth, a surgeon from North Mississippi, the use of Caldolor before surgery can help minimize the effects of opioid use and improve the recovery of patients. During the pre-pandemic situation, many healthcare systems in all parts of the US were working to control surgical pain by decreasing opioid consumption. As a result, Cumberland’s Caldolor was widely used in hospitals.